For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Research and development | 103,827 | 146,705* | 141,169 | 184,367 |
| General and administrative | 26,601 | 26,993* | 28,213 | 27,334 |
| Total operating expenses | 130,428 | 173,697 | 169,382 | 211,701 |
| Loss from operations | -130,428 | -173,697* | -169,382 | -211,701 |
| Other income, net | - | -6,964 | - | - |
| Other income, net | 168 | -6,964* | -3,840 | 13,815 |
| Loss before provision for income taxes | -130,260 | -180,662* | -173,222 | -197,886 |
| Provision for income taxes | 272 | 719* | 221 | 261 |
| Net loss | -130,532 | -181,381 | -173,443 | -198,147 |
| Other comprehensive loss, net of tax | -46 | - | 39 | -76 |
| Comprehensive loss | -130,578 | - | -173,404 | -198,223 |
| Basic EPS | -0.88 | -1.582 | -1.64 | -1.94 |
| Diluted EPS | -0.88 | -1.582 | -1.64 | -1.94 |
| Basic Average Shares | 147,615,197 | 114,686,797 | 105,815,038 | 102,372,820 |
| Diluted Average Shares | 147,615,197 | 114,686,797 | 105,815,038 | 102,372,820 |
Biohaven Ltd. (BHVN)
Biohaven Ltd. (BHVN)